FIND releases summary from malaria diagnostics meeting

FIND officials recently released a summary about a meeting held in Philadelphia last fall where they discussed creating new diagnostic solutions for Plasmodium vivax malaria. Read More »

FIND and McGill University enter agreement to focus on TB diagnostics

FIND recently made an agreement with the Research Institute of the McGill University Health Centre in Montreal to concentrate their united efforts on tuberculosis (TB) diagnostics. Read More »

WHO releases results from reviews of rapid malaria tests

The World Health Organization (WHO) recently released the results of its review of rapid diagnostic tests (RDT) that are designed to detect malaria from the parasites inside the host. Read More »

Trial applications sought for FIND and Cepheid diagnosis tools

FIND and Cepheid recently requested trial applications to evaluate the effect and performance of diagnosing rifampicin resistance and tuberculosis (TB) using the GeneXpert Omni system from Cepheid when it is used along with the Xpert MTB/RIF Ultra assay. Read More »

FIND teams with Cepheid to improve TB care in low- and middle-income countries

FIND and Cepheid have extended their partnership to include point-of-care tuberculosis (TB) diagnosis, which they intend to bring to health systems throughout low- and middle-income countries (LMIC). Read More »

FIND and Janssen partner to fight tuberculosis

FIND and Janssen Pharmaceutical NV recently developed a new collaborative agreement to make tuberculosis (TB) diagnosis, treatment and care more accessible to patients around the world. Read More »

FIND and QIAGEN improve collaboration for novel TB tests

FIND and QIAGEN recently signed a memorandum of understanding for the next five years that will formalize their collaboration in furthering diagnostic tests for tuberculosis. Read More »

Faster test detects rifampicin resistance to TB

A large-scale study recently published in PLoS One suggests that using Xpert MTB/RIF as the first test to detect tuberculosis (TB) in India‚Äôs public health facilities may notably improve the number of cases diagnosed. Read More »

QuantuMDx Group joins FIND effort to improve tuberculosis-detection techniques

QuantuMDx Group joins the Foundation for Innovative New Diagnostics' list of partners (including Cepheid and Rutgers New Jersey Medical School) in an effort to develop a single solution for both detecting tuberculosis and discovering the cause of the disease. Read More »